Annual Revenues

 
News Articles for Annual Revenues top ^
2014/11/18
By Alex MacDonald LONDON--U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.
Sign-up for AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 -- Update investment picks
http://media.marketwire.com/attachments/201312/69900_StockMarketMediaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145652&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for LiveDeal, Inc. Acquisition Adds an Expected $10 Million in Annual Revenues and Growing investment picks
2014/11/18
By Alex MacDonald LONDON--U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.
Sign-up for AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 investment picks
PGi's Transition Accelerates, with Over 70% of SaaS Sales to Existing Customer Base; Third Quarter Revenues Up Nearly 8% to $140.4M; Non-GAAP Diluted EPS from Continuing Ops $0.22* ATLANTA , Oct.
Sign-up for PGi Milestone: SaaS Products Hit $66 Million Annual Revenue Run-Rate, Exceeding 10% of Consolidated Revenues Run-Rate investment picks
Accenture (NYSE:ACN) reported financial results for the fourth quarter and full fiscal year ended Aug.
Sign-up for Accenture Reports Fourth-Quarter and Full-Year Fiscal 2014 Results, With Record Annual Revenues and New Bookings investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Annual Revenues
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Annual Results  |  Next: Annual Scientific